GRAIL Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GRAL research report →
About the company
GRAIL, Inc. , a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer.
- CEO
- Robert Ragusa
- IPO
- 2024
- Employees
- 910
- HQ
- Menlo Park, CA, US
Price Chart
- Market Cap
- $2.97B
- P/E
- -6.66
- P/S
- 19.00
- P/B
- 1.12
- EV/EBITDA
- -8.73
- Div Yield
- 0.00%
- Gross Margin
- -14.80%
- Op Margin
- -348.66%
- Net Margin
- -253.22%
- ROE
- -16.42%
- ROIC
- -15.24%
- Revenue
- $147.17M · 17.18%
- Net Income
- $-408,351,000 · 79.85%
- EPS
- $-11.11 · 82.51%
- Op Income
- $-534,163,000
- FCF YoY
- 48.66%
- 52W High
- $118.84
- 52W Low
- $29.95
- 50D MA
- $61.66
- 200D MA
- $72.77
- Beta
- 3.22
- Avg Volume
- 739.97K
Get TickerSpark's AI analysis on GRAL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 18, 26 | CHASE WILLIAM J | other | 5,491 |
| Jun 18, 26 | MIZELL STEVEN | other | 5,491 |
| Jun 18, 26 | SUMME GREGORY L | other | 5,491 |
| Jun 18, 26 | Krevans Sarah | other | 5,491 |
| Jun 4, 26 | Partridge Andrew John | sell | 1,491 |
| Jun 3, 26 | Ofman Joshua J. | other | 3,154 |
| Jun 1, 26 | Ofman Joshua J. | other | 27,901 |
| Jun 1, 26 | Partridge Andrew John | other | 0 |
| Apr 15, 26 | MIZELL STEVEN | other | 396 |
| Apr 15, 26 | CHASE WILLIAM J | other | 408 |
Our GRAL coverage
Recent articles, reports, and earnings notes.
No research on GRAL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GRAL report →Similar companies
Peers in the same neighborhood.